Bank of America’s Trinity Biotech TRIB Stock Holding History

Bank of America’s Portfolio TRIB Stock Details TRIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-37	Closed	-$867	–	6833
2025 Q4	$867	Buy	37 +36	+3,600%	+$1.06K	﹤0.01%	6484
2025 Q3	$42	Sell	1 -2	-67%	-$63	﹤0.01%	8050
2025 Q2	$52	Buy	3 +2	+200%	+$40	﹤0.01%	8093
2025 Q1	$23	Sell	1 -7	-88%	-$166	﹤0.01%	8111
2024 Q4	$211	Hold	8	–	–	﹤0.01%	7575
2024 Q3	$264	Hold	8	–	–	﹤0.01%	7511
2024 Q2	$511	Hold	8	–	–	﹤0.01%	7358
2024 Q1	$490	Hold	8	–	–	﹤0.01%	7276
2023 Q4	$516	Hold	8	–	–	﹤0.01%	7279
2023 Q3	$885	Hold	8	–	–	﹤0.01%	7248
2023 Q2	$1.15K	Hold	8	–	–	﹤0.01%	7224
2023 Q1	$1.13K	Hold	8	–	–	﹤0.01%	7291
2022 Q4	$1.19K	Hold	8	–	–	﹤0.01%	7319
2022 Q3	$1K	Hold	8	–	–	﹤0.01%	7697
2022 Q2	$1K	Hold	8	–	–	﹤0.01%	7893
2022 Q1	$1K	Hold	8	–	–	﹤0.01%	8140
2021 Q4	$2K	Hold	8	–	–	﹤0.01%	8004
2021 Q3	$3K	Hold	8	–	–	﹤0.01%	7842
2021 Q2	$4K	Sell	8 -1	-11%	-$499	﹤0.01%	7465
2021 Q1	$5K	Hold	9	–	–	﹤0.01%	7129
2020 Q4	$5K	Sell	9 -2	-18%	-$993	﹤0.01%	6829
2020 Q3	$3K	Hold	11	–	–	﹤0.01%	6668
2020 Q2	$4K	Hold	11	–	–	﹤0.01%	6593
2020 Q1	$2K	Hold	11	–	–	﹤0.01%	6651
2019 Q4	$2K	Hold	11	–	–	﹤0.01%	6904
2019 Q3	$2K	Hold	11	–	–	﹤0.01%	7015
2019 Q2	$3K	Sell	11 -2	-15%	-$714	﹤0.01%	6916
2019 Q1	$6K	Buy	13 +7	+117%	+$2.89K	﹤0.01%	6770
2018 Q4	$3K	Buy	6 +2	+50%	+$926	﹤0.01%	6851
2018 Q3	$3K	Hold	4	–	–	﹤0.01%	6966
2018 Q2	$3K	Hold	4	–	–	﹤0.01%	6875
2018 Q1	$3K	Buy	4 +1	+33%	+$818	﹤0.01%	6856
2017 Q4	$2K	Sell	3 -5	-63%	-$3.87K	﹤0.01%	6865
2017 Q3	$6K	Sell	8 -41	-84%	-$34.3K	﹤0.01%	6684
2017 Q2	$44K	Hold	49	–	–	﹤0.01%	5924
2017 Q1	$43K	Hold	49	–	–	﹤0.01%	5996
2016 Q4	$50K	Buy	49 +38	+345%	+$39.3K	﹤0.01%	5927
2016 Q3	$22K	Buy	11 +8	+267%	+$14.9K	﹤0.01%	6099
2016 Q2	$5K	Buy	3 +1	+50%	+$1.69K	﹤0.01%	6680
2016 Q1	$3K	Buy	+2	New	+$3.18K	﹤0.01%	6709
2015 Q4	–	Sell	-11	Closed	-$19K	–	7470
2015 Q3	$19K	Buy	11 +9	+450%	+$21.7K	﹤0.01%	6326
2015 Q2	$5K	Sell	2 -1	-33%	-$2.6K	﹤0.01%	6820
2015 Q1	$10K	Hold	3	–	–	﹤0.01%	6306
2014 Q4	$9K	Sell	3 -320	-99%	-$827K	﹤0.01%	7109
2014 Q3	$886K	Buy	323 +322	+32,200%	+$1.05M	﹤0.01%	4078
2014 Q2	$3K	Sell	1 -1	-50%	-$3.56K	﹤0.01%	7760
2014 Q1	$8K	Hold	2	–	–	﹤0.01%	7252
2013 Q4	$8K	Buy	+2	New	+$7.2K	﹤0.01%	7363

Other funds holding TRIB

HAIM

Hunter Associates Investment Management Pittsburgh, Pennsylvania $868M AUM 32.25% 1-Year Est. Return

YAG

Yorkville Advisors Global Mountainside, New Jersey $155M AUM 58.46% 1-Year Est. Return

Williams & Novak Westlake Village, California $151M AUM 27.43% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

MAWA

Moss Adams Wealth Advisors Seattle, Washington $1.6B AUM 28.24% 1-Year Est. Return

IWA

Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

BCM

Becker Capital Management Portland, Oregon $3.4B AUM 24.68% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of America's TRIB Position: Q1 2026 in Review

Bank of America sold out of Trinity Biotech (TRIB) in Q1 2026, closing a stake of 37 shares — an estimated $867 sold.

Bank of America first reported a position in TRIB in Q4 2013 and held it in 48 quarters. The position peaked at $886K in Q3 2014. 21 funds tracked by Wall St. Rank hold TRIB as of Q1 2026.

Bank of America reported no remaining Trinity Biotech position as of Q1 2026 after selling out during the quarter.
Bank of America sold 37 Trinity Biotech shares in Q1 2026, an estimated $867.
Bank of America first reported a position in Trinity Biotech in Q4 2013 and held it in 48 quarters.
Bank of America's Trinity Biotech position peaked at $886K in Q3 2014.
21 funds tracked by Wall St. Rank held Trinity Biotech as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.